Literature DB >> 20707406

Sensitization of non-small cell lung cancer cells to cisplatin by naturally occurring isothiocyanates.

Anthony J Di Pasqua1, Charles Hong, Mona Y Wu, Erin McCracken, Xiantao Wang, Lixin Mi, Fung-Lung Chung.   

Abstract

We show that naturally occurring isothiocyanates (ITCs) sensitize human non-small cell lung cancer cells to cisplatin. Moreover, the structure of the ITC side chain moiety is important for sensitization. In NCI-H596 cells, 20 microM benzyl isothiocyanate (BITC) and phenethyl isothiocyanate (PEITC) enhance the efficacy of various concentrations of cisplatin, but sulforaphane (SFN) does not. Reducing the concentration of BITC and PEITC to 10 microM still allows for the sensitization of cells to cisplatin. Neither cellular platinum accumulation nor DNA platination account for this increased cytotoxicity. BITC and PEITC deplete beta-tubulin, but SFN does not; this correlates with and may be important for sensitization.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20707406      PMCID: PMC2924773          DOI: 10.1021/tx100187f

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  26 in total

Review 1.  The role of cellular accumulation in determining sensitivity to platinum-based chemotherapy.

Authors:  Matthew D Hall; Mitsunori Okabe; Ding-Wu Shen; Xing-Jie Liang; Michael M Gottesman
Journal:  Annu Rev Pharmacol Toxicol       Date:  2008       Impact factor: 13.820

2.  The mechanism of action of platinum anticancer agents--what do we really know about it?

Authors:  Dan Gibson
Journal:  Dalton Trans       Date:  2009-10-20       Impact factor: 4.390

3.  p53-Dependent and -independent responses to cisplatin in mouse testicular teratocarcinoma cells.

Authors:  D B Zamble; T Jacks; S J Lippard
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

4.  High-performance liquid chromatography-based determination of total isothiocyanate levels in human plasma: application to studies with 2-phenethyl isothiocyanate.

Authors:  L Liebes; C C Conaway; H Hochster; S Mendoza; S S Hecht; J Crowell; F L Chung
Journal:  Anal Biochem       Date:  2001-04-15       Impact factor: 3.365

Review 5.  Isothiocyanates: mechanism of cancer chemopreventive action.

Authors:  Paul J Thornalley
Journal:  Anticancer Drugs       Date:  2002-04       Impact factor: 2.248

6.  Role of carbonate in the cytotoxicity of carboplatin.

Authors:  Anthony J Di Pasqua; Jerry Goodisman; Deborah J Kerwood; Bonnie B Toms; Ronald L Dubowy; James C Dabrowiak
Journal:  Chem Res Toxicol       Date:  2007-05-12       Impact factor: 3.739

Review 7.  Paclitaxel for non-small cell lung cancer.

Authors:  Sakkaraiappan Ramalingam; Chandra P Belani
Journal:  Expert Opin Pharmacother       Date:  2004-08       Impact factor: 3.889

Review 8.  Isothiocyanates as cancer chemopreventive agents: their biological activities and metabolism in rodents and humans.

Authors:  C Clifford Conaway; Yang-Ming Yang; Fung-Lung Chung
Journal:  Curr Drug Metab       Date:  2002-06       Impact factor: 3.731

9.  Sulforaphane protects against cisplatin-induced nephrotoxicity.

Authors:  Carlos Enrique Guerrero-Beltrán; Mariel Calderón-Oliver; Edilia Tapia; Omar N Medina-Campos; Dolores Javier Sánchez-González; Claudia María Martínez-Martínez; Karla Mariana Ortiz-Vega; Martha Franco; José Pedraza-Chaverri
Journal:  Toxicol Lett       Date:  2009-11-12       Impact factor: 4.372

10.  Administration of isothiocyanate (E-4IB) and cisplatin leads to altered signalling and lysosomal export in human ovarian carcinoma sensitive- and cisplatin-resistant cells.

Authors:  J Duraj; L Hunakova; J Bodo; J Jakubikova; J Chovancova; J Sedlak
Journal:  Neoplasma       Date:  2009       Impact factor: 2.575

View more
  14 in total

Review 1.  Cancer chemoprevention with dietary isothiocyanates mature for clinical translational research.

Authors:  Shivendra V Singh; Kamayani Singh
Journal:  Carcinogenesis       Date:  2012-06-27       Impact factor: 4.944

2.  Synergistic effect of allyl isothiocyanate (AITC) on cisplatin efficacy in vitro and in vivo.

Authors:  Xiang Ling; David Westover; Felicia Cao; Shousong Cao; Xiang He; Hak-Ryul Kim; Yuesheng Zhang; Daniel Cf Chan; Fengzhi Li
Journal:  Am J Cancer Res       Date:  2015-07-15       Impact factor: 6.166

3.  Sulforaphane, a natural constituent of broccoli, prevents cell death and inflammation in nephropathy.

Authors:  Carlos Enrique Guerrero-Beltrán; Partha Mukhopadhyay; Béla Horváth; Mohanraj Rajesh; Edilia Tapia; Itzhel García-Torres; José Pedraza-Chaverri; Pál Pacher
Journal:  J Nutr Biochem       Date:  2011-06-17       Impact factor: 6.048

4.  Phenethyl isothiocyanate sensitizes human cervical cancer cells to apoptosis induced by cisplatin.

Authors:  Xiantao Wang; Sudha Govind; Shyama P Sajankila; Lixin Mi; Rabindra Roy; Fung-Lung Chung
Journal:  Mol Nutr Food Res       Date:  2011-05-19       Impact factor: 5.914

Review 5.  Molecular targets of isothiocyanates in cancer: recent advances.

Authors:  Parul Gupta; Bonglee Kim; Sung-Hoon Kim; Sanjay K Srivastava
Journal:  Mol Nutr Food Res       Date:  2014-02-10       Impact factor: 5.914

6.  Inhibition of mitochondrial fusion is an early and critical event in breast cancer cell apoptosis by dietary chemopreventative benzyl isothiocyanate.

Authors:  Anuradha Sehrawat; Claudette St Croix; Catherine J Baty; Simon Watkins; Dhanir Tailor; Rana P Singh; Shivendra V Singh
Journal:  Mitochondrion       Date:  2016-06-30       Impact factor: 4.160

7.  Liposome Delivery of Natural STAT3 Inhibitors for the Treatment of Cancer.

Authors:  Max Kullberg; Alexandra Francian; Ameneh Arabi; Troy Olsson; Kristine Mann; Holly A Martinson
Journal:  Pharm Front       Date:  2019-11-28

8.  Chemo-predictive assay for targeting cancer stem-like cells in patients affected by brain tumors.

Authors:  Sarah E Mathis; Anthony Alberico; Rounak Nande; Walter Neto; Logan Lawrence; Danielle R McCallister; James Denvir; Gerrit A Kimmey; Mark Mogul; Gerard Oakley; Krista L Denning; Thomas Dougherty; Jagan V Valluri; Pier Paolo Claudio
Journal:  PLoS One       Date:  2014-08-21       Impact factor: 3.240

9.  Cisplatin in combination with Phenethyl Isothiocyanate (PEITC), a potential new therapeutic strategy for malignant pleural mesothelioma.

Authors:  Iza Denis; Laurent Cellerin; Marc Gregoire; Christophe Blanquart
Journal:  Oncotarget       Date:  2014-11-30

10.  Phenylethyl isothiocyanate reverses cisplatin resistance in biliary tract cancer cells via glutathionylation-dependent degradation of Mcl-1.

Authors:  Qiwei Li; Ming Zhan; Wei Chen; Benpeng Zhao; Kai Yang; Jie Yang; Jing Yi; Qihong Huang; Man Mohan; Zhaoyuan Hou; Jian Wang
Journal:  Oncotarget       Date:  2016-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.